Bonovo Orthopedics Inks $10M Series C

U.S. and China-based Bonovo Orthopedics has raised $10 million in a Series C financing led by OrbiMed Asia Partners. The round, which includes participation from Beijing-based Legend Capital, brings the company’s total financing to $16.5 million. Bonovo will use the money to expand its sales and continue product development. Formed in 2008, Bonovo manufactures implants and other orthopedic products for the Chinese healthcare market.

North AmericaUSBriefs